A new selective, and sensitive method for the determination of lixivaptan, a vasopressin 2 (V2)-receptor antagonist, in mouse plasma and its application in a pharmacokinetic study
A new, selective and sensitive HPLC method for the determination of lixivaptan, an oral selective vasopressin 2 (V2)-receptor antagonist, was investigated and validated. A Waters symmetry C18 column was used as a stationary phase in isocratic elution mode using a mobile phase composed of KH2PO4 (100...
Main Authors: | Alrabiah Haitham, Abunassif Mohammed, Attia Sabry, Mostafa Gamal Abdel-Hafiz |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2018-07-01
|
Series: | Open Chemistry |
Subjects: | |
Online Access: | https://doi.org/10.1515/chem-2018-0063 |
Similar Items
-
Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells
by: Annarita Di Mise, et al.
Published: (2019-12-01) -
Development and Validation of an HPLC-UV Detection Assay for the Determination of Clonidine in Mouse Plasma and Its Application to a Pharmacokinetic Study
by: Haitham AlRabiah, et al.
Published: (2020-09-01) -
A New Validated HPLC-MS/MS Method for Quantification and Pharmacokinetic Evaluation of Dovitinib, a Multi-Kinase Inhibitor, in Mouse Plasma
by: AlRabiah H, et al.
Published: (2020-01-01) -
A randomized two-way crossover comparative pharmacokinetic study of two different tablet formulations containing ilaprazole in healthy human Indian volunteers
by: Shubhasis Dan, et al.
Published: (2014-01-01) -
Pharmacokinetic Comparison of Epinastine Using Developed Human Plasma Assays
by: Seung-Hyun Jeong, et al.
Published: (2020-01-01)